Allergies and hypersensitivity reactions are increasingly prevalent, affecting millions worldwide and significantly impacting daily life. Mass cytometry has emerged as a powerful tool for unraveling the complex immune responses underlying these conditions, offering new insights that translate into practical benefits for patients.
Profiling Allergen-Specific Immune Responses
Mass cytometry has revolutionized our ability to characterize allergen-specific immune responses with unprecedented detail. The groundbreaking study by Chiang et al. (2018) in the Journal of Allergy and Clinical Immunology used single-cell RNA sequencing and flow cytometry to profile peanut-responsive T cells in patients with peanut allergy. They uncovered heterogeneous effector TH2 subsets, revealing a complexity in allergic responses previously unappreciated.
This detailed understanding could lead to more precise diagnostic tests. For instance, a child suspected of having a peanut allergy might undergo a blood test analyzed by mass cytometry, potentially avoiding the need for risky oral food challenges. The test could not only confirm the allergy but also provide information about its severity, allowing for more tailored management strategies.
Restricted content
You must be logged in and have a valid subscription to see this content. Please visit our subscription page for more info. If you are already a VIP member, be sure you are logged in with the same email address you made your purchase.
From the lab bench to the factory floor, my journey through immunology has been quite the ride. At Novartis Huningue, I found myself elbow-deep in the production of Xolair, an anti-IgE monoclonal antibody that's a lifesaver for allergy sufferers. It was like watching the circle of life, but for antibodies - from discovery to large-scale production, all under one roof. But the real fun? That was back in the lab, brewing up our very own PDL1 antibodies. Let me tell you, producing antibodies is less like haute cuisine and more like milking a very, very tiny cow. There I was, coaxing these microscopic factories to churn out our cellular gold. It was oddly satisfying, like being a farmer for science. From pipetting microliters to overseeing hectoliters, I've seen antibodies in all their glory. It's a strange world where the same principles apply whether you're making a thimbleful or a swimming pool's worth of antibodies.
